Department of Nursing, Pharmacology and Physiotherapy, Faculty of Medicine and Nursing, University of Cordoba, 14004, Cordoba, Spain.
Lifestyles, Innovation and Health Research Associate Group, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004, Cordoba, Spain.
Pediatr Res. 2023 Nov;94(5):1824-1831. doi: 10.1038/s41390-023-02693-0. Epub 2023 Jun 12.
A variable percentage of children and adolescents with obesity do not have cardiometabolic comorbidities. A phenotype called metabolically healthy obese (MHO) has emerged to describe this population subgroup. Early identification of this condition may prevent the progression to metabolically unhealthy obesity (MUO).
A cross-sectional descriptive study of 265 children and adolescents from Cordoba (Spain) conducted in 2018. The outcome variables were MHO, established based on three criteria: International Criterion, HOMA-IR, and a combination of the previous two.
The prevalence of MHO ranged from 9.4% to 12.8% of the study population, between 41% and 55.7% of the sample with obesity. The highest agreement was reached between the HOMA-IR definitions and the combined criteria. The waist-to-height ratio (WHtR) was the indicator with the highest discriminant capacity for MHO in 2 of the three criteria, with its best cut-off point at 0.47 for both.
The prevalence of MHO in children and adolescents differed according to the criteria used for diagnosis. The anthropometric variable with the most remarkable discriminating capacity for MHO was WHtR, with the same cut-off point in the three criteria analysed.
This research work defines the existence of metabolically healthy obesity through anthropometric indicators in children and adolescents. Definitions that combine cardiometabolic criteria and insulin resistance are used to identify metabolically healthy obesity, as well as the prediction of this phenomenon through anthropometric variables. The present investigation helps to identify metabolically healthy obesity before metabolic abnormalities begin.
肥胖儿童和青少年中存在一定比例的人群不伴有代谢并发症。代谢健康型肥胖(MHO)这一表型的出现描述了这一亚组人群。早期识别这种情况可能会阻止向代谢不健康型肥胖(MUO)的进展。
这是 2018 年在西班牙科尔多瓦进行的一项针对 265 名儿童和青少年的横断面描述性研究。根据三个标准,将代谢健康型肥胖定义为结局变量:国际标准、HOMA-IR 以及前两个标准的组合。
MHO 的患病率在研究人群中为 9.4%至 12.8%,肥胖样本中为 41%至 55.7%。HOMA-IR 定义和联合标准之间的一致性最高。在三个标准中的两个标准中,腰围身高比(WHtR)是 MHO 最具判别能力的指标,最佳截断点均为 0.47。
根据用于诊断的标准,儿童和青少年的 MHO 患病率存在差异。对 MHO 具有最显著判别能力的人体测量变量是 WHtR,三个分析标准的最佳截断点均相同。
这项研究工作通过儿童和青少年的人体测量指标定义了代谢健康型肥胖的存在。使用联合了心血管代谢标准和胰岛素抵抗的定义来识别代谢健康型肥胖,并通过人体测量变量来预测这种现象。本研究有助于在代谢异常发生之前识别代谢健康型肥胖。